Found 773 matching trials
A Phase II Prospective, Open-Label, Randomized, Multicenter Study of Kangfu Spray for the Prevention of Radiation-Induced Oral Mucositis in Patients With Oral Malignancies Receiving Intensity-Modulated Radiotherapy NA This is a prospective, open-label, randomized, controlled, multicenter phas...
Show More Location
Multiple Locations
Learn More & Join Trial
Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy PHASE2 Radiotherapy can activate local and systemic immune responses through a var...
Show More Location
Multiple Locations
Learn More & Join Trial
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma PHASE2 The purpose of this study is to determine whether the addition of acupunctu...
Show More Location
The Christie NHS Foundation Trust
Learn More & Join Trial
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy PHASE2 Chemotherapy induced nausea and vomiting (CINV) is a major adverse effect o...
Show More Location
Princess Margaret Hospital
Learn More & Join Trial
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic Chemotherapy PHASE3 This phase III, multicenter, randomized, open-label trial evaluates whether...
Show More Location
Multiple Locations
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients PHASE2 Mucositis is a common and clinically significant side effect of both antica...
Show More Learn More & Join Trial
Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer PHASE1 This study will evaluate the ability of grape exosomes, given to the subjec...
Show More Location
James Graham Brown Cancer Center
Learn More & Join Trial
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old PHASE1 A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Show More Location
Hospital Universitario Príncipe de Asturias
Learn More & Join Trial